On July 16, the U.S. Food and Drug Administration (FDA) approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.
Read more.

FDA approves new product to treat hereditary angioedema

FDA approves drug for treating rare type of non-Hodgkin lymphoma

FDA approves Afrezza

Lessons for more efficient research in healthcare settings

Study: Fecal microbiota transplant effective in immunocompromised patients

Bullying toolkit available

Study: Higher Hgb or receiving EPO doesn’t improve neuro outcomes in patients with TBI

Study: Nearly 80% of deaths in first three decades of life traced to unintentional injury or violence

International home care conference

What you can learn from failure

Achieving a work-life balance

Writing for good health

Nursing the dead: Medicolegal death scene investigation

Improving HCAHPS scores the old fashioned way

Key concepts in patient-centered care

Managing knee osteoarthritis in older adults

Health, safety, & wellness

Issues up close

Leadership insights

From the ANA CEO

An ending and a new beginning for American Nurse Today

Reducing sepsis deaths: A systems approach to early detection and management

July 2014 e-Edition

FDA approves new drug for serious skin infections

FDA approves new indication for imaging agent

New MRI technique may help in early diagnosis of Parkinson’s disease

FDA launches new website for accessing health databases

Guidelines for abdominal aortic aneurysm screening released

Study: Too much TV viewing can increase mortality

Study: Thrombolytics significantly reduce mortality in sudden-onset PE

Study: TV violence may affect brain development in young adult men

CDC analysis of foodborne norovirus outbreaks

At least 10% of MI patient may have undiagnosed diabetes

Beyond thank you: The powerful reach of meaningful recognition

Shaving as a metaphor for nursing

Update on home health care: How it’s changing